Interestingly, TET2 nuclear localization is decreased in invasive and in situ ductal BC tissue samples compared to normal breast tissue samples and correlates with higher BMI, lymph node metastasis, poor differentiation, and basal-like molecular subtype [30]. This evidence concerns the gene TET2 and breast cancer.